Previous studies found that apigenin inhibited the invasion and migration of human metastatic cancer cell lines by reducing MMP-9 expression by suppressing the p38 MAPK signaling pathways (Noh et al., 2010). The gene discussed is MMP9; the disease is metastatic malignant neoplasm.